Clinical Trials, page-191

Congratulation to those bought in at 155 before breakout and to those with faith to hold till now after breaking ATH.

IMO this is just beginning... SP rectified itself after previous few announcement on successful results of covic 19 and P2 cancer trial. which should have been so.

Thing to consider from here.
We are on the edge of commercial deal with Vet Major (500 fortune). as witness @Esk announce partnership with samsung without commercial or revenue indication ... ESK manage to run from this range to $3.47 within 2 days. @paa we talking about commercial deal penetrating cancer market of 52bil.

Secondly express ticket toward human trial on covic 19 and may be towards commercial deal with market of 100bil.
Covic 19 pandemic pushing all countries around the world seeking for vacines & treatment. @paa we already in front seat in human safety and successful preclinical test with 95% suppression. Furthermore if we get any positive indication on imminent human test, things will moving quickly @paa. Fund and support from not just FDA approval / Aust Gov but could be worldwide.
Take instance FDA approval at ATH... sending its sp to 1000% plus. remdesivir struck deal with US gov on full production for being test with sign of recovery reduction time. while steroid dexamethasone give chance 1 in 8 reduction death rate.
As you can see the world in desperate moment, which could pushing PAA to struck deal or even towards production etc.
So I am very keen on this next human trial result.

We are now on spotlight at many dimension today.
So hold on tight... even small amount of your holding can be very nice reward.

GLTA!